HealthEquity, Inc. (NASDAQ:HQY) Sees Significant Decline in Short Interest

HealthEquity, Inc. (NASDAQ:HQYGet Rating) saw a large decrease in short interest in the month of August. As of August 31st, there was short interest totalling 3,620,000 shares, a decrease of 7.7% from the August 15th total of 3,920,000 shares. Approximately 4.4% of the shares of the company are short sold. Based on an average daily trading volume, of 765,800 shares, the days-to-cover ratio is currently 4.7 days.

Insider Buying and Selling

In related news, COO Edward Bloomberg sold 1,000 shares of the stock in a transaction that occurred on Monday, August 1st. The shares were sold at an average price of $57.63, for a total value of $57,630.00. Following the transaction, the chief operating officer now owns 59,850 shares in the company, valued at approximately $3,449,155.50. The sale was disclosed in a filing with the SEC, which is available through this link. 2.80% of the stock is owned by corporate insiders.

Institutional Trading of HealthEquity

Hedge funds have recently bought and sold shares of the business. Private Trust Co. NA acquired a new stake in shares of HealthEquity during the 2nd quarter worth approximately $28,000. Assetmark Inc. increased its holdings in shares of HealthEquity by 387.1% during the 2nd quarter. Assetmark Inc. now owns 755 shares of the company’s stock worth $46,000 after buying an additional 600 shares during the last quarter. Signaturefd LLC increased its holdings in shares of HealthEquity by 44.3% during the 1st quarter. Signaturefd LLC now owns 954 shares of the company’s stock worth $64,000 after buying an additional 293 shares during the last quarter. Clearstead Advisors LLC acquired a new stake in shares of HealthEquity during the 1st quarter worth approximately $65,000. Finally, Eagle Bay Advisors LLC increased its holdings in shares of HealthEquity by 137.8% during the 2nd quarter. Eagle Bay Advisors LLC now owns 1,108 shares of the company’s stock worth $68,000 after buying an additional 642 shares during the last quarter. Institutional investors and hedge funds own 99.43% of the company’s stock.

HealthEquity Trading Up 0.7 %

HQY stock opened at $71.88 on Tuesday. The company has a market cap of $6.08 billion, a price-to-earnings ratio of -97.14, a PEG ratio of 4.25 and a beta of 0.90. HealthEquity has a 12 month low of $36.81 and a 12 month high of $73.29. The firm has a 50-day moving average of $62.21 and a two-hundred day moving average of $62.51.

HealthEquity (NASDAQ:HQYGet Rating) last released its quarterly earnings data on Tuesday, September 6th. The company reported $0.33 EPS for the quarter, meeting analysts’ consensus estimates of $0.33. HealthEquity had a negative net margin of 7.82% and a positive return on equity of 2.86%. During the same period in the prior year, the business posted $0.21 earnings per share. As a group, equities analysts forecast that HealthEquity will post 0.69 earnings per share for the current year.

Wall Street Analysts Forecast Growth

HQY has been the subject of several recent research reports. The Goldman Sachs Group assumed coverage on shares of HealthEquity in a report on Tuesday, July 12th. They set a “sell” rating and a $59.00 target price for the company. Wells Fargo & Company increased their target price on shares of HealthEquity from $95.00 to $100.00 and gave the stock an “overweight” rating in a research note on Tuesday, September 13th. Barrington Research increased their target price on shares of HealthEquity from $70.00 to $75.00 in a research note on Tuesday, June 7th. Raymond James increased their target price on shares of HealthEquity from $70.00 to $75.00 and gave the stock an “outperform” rating in a research note on Monday, September 12th. Finally, KeyCorp began coverage on shares of HealthEquity in a research note on Thursday, September 15th. They set an “overweight” rating and a $85.00 target price on the stock. Two equities research analysts have rated the stock with a sell rating, one has given a hold rating and eleven have given a buy rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $75.36.

HealthEquity Company Profile

(Get Rating)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Recommended Stories

Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.